BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20853670)

  • 1. The intradermal vaccination: past experiences and current perspectives.
    Sticchi L; Alberti M; Alicino C; Crovari P
    J Prev Med Hyg; 2010 Mar; 51(1):7-14. PubMed ID: 20853670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of influenza by use of intradermal vaccination].
    Kyncl J
    Cas Lek Cesk; 2009; 148(5):191-3. PubMed ID: 19642311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an adsorbed trivalent split influenza vaccine administered by intradermal route.
    Niculescu IT; Zilişteanu E; Alexandrescu V; Maţepiuc M; Creţescu L; Ionescu N; Molnar G; Răcăşan R; Mogoş A
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):67-70. PubMed ID: 7185350
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
    Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
    Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 9. [New options of influenza vaccination].
    Chlíbek R
    Cas Lek Cesk; 2010; 149(3):111-4. PubMed ID: 20429345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal vaccination for infants and children.
    Saitoh A; Aizawa Y
    Hum Vaccin Immunother; 2016 Sep; 12(9):2447-55. PubMed ID: 27135736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL
    Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity of intradermal influenza vaccination in COPD patients.
    Chuaychoo B; Wongsurakiat P; Nana A; Kositanont U; Maranetra KN
    Vaccine; 2010 May; 28(24):4045-51. PubMed ID: 20412877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An early-type hypersensitivity (ETH) to hepatitis B surface antigen as a quick and economic screening test for a vaccination program.
    Barone P; Leonardi S; Oggiano R; Musumeci S
    Ann Ig; 1998; 10(2):121-4. PubMed ID: 9658674
    [No Abstract]   [Full Text] [Related]  

  • 16. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular versus intradermal hepatitis B vaccination.
    Milne A
    N Z Med J; 1986 Aug; 99(808):640. PubMed ID: 2944039
    [No Abstract]   [Full Text] [Related]  

  • 19. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination.
    Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M
    Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of low dose intradermal hepatitis B vaccine and its comparison with standard dose intramuscular vaccination.
    Gomber S; Sharma R; Ramachandran VG
    Indian Pediatr; 2004 Sep; 41(9):922-6. PubMed ID: 15475635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.